3.
Univariate and multivariate analyses of PFS and multivariate analyses of OS in RH group
| Characteristics | PFS | OS | |||||||||
| Univariate analysis | Multivariate analysis | Multivariate analysis | |||||||||
| HR | 95% CI | P | HR | 95% CI | P | HR | 95% | P | |||
| PFS, progression-free survival; OS, overall survival; RH, radical hysterectomy; HPV, human papillomavirus; FIGO, International Federation of Gynecology and Obstetrics; LNM, lymph node metastasis; SCC-Ag, squamous cell carcinoma antigen; HR, hazard ratio; 95% CI, 95% confidence interval. *, SCC-Ag level was modeled as continuous variables, and the risk of disease progression was increased by 3.4% in univariate analysis with each 1 ng/mL of SCC-Ag increment. | |||||||||||
| HPV viral load | |||||||||||
| >Median | 1 | 1 | 1 | ||||||||
| ≤Median | 4.414 | 2.039−9.557 | 0.0001 | 4.198 | 1.933−9.116 | 0.0003 | 3.853 | 1.766−8.404 | 0.0007 | ||
| FIGO stage | |||||||||||
| IB1 | 1 | 1 | 1 | ||||||||
| IB2 | 1.885 | 0.921−3.855 | 0.0827 | 1.401 | 0.668−2.941 | 0.3720 | 1.387 | 0.646−2.976 | 0.4011 | ||
| IIA | 4.489 | 2.061−9.777 | 0.0002 | 3.526 | 1.574−7.899 | 0.0020 | 3.622 | 1.600−8.201 | 0.0027 | ||
| LNM | |||||||||||
| Negative | 1 | 1 | 1 | ||||||||
| Positive | 4.705 | 2.527−8.726 | <0.001 | 3.586 | 1.872−6.870 | 0.0001 | 4.284 | 2.205−8.322 | <0.0001 | ||
| Post-surgery adjuvant treatment | |||||||||||
| No | 1 | ||||||||||
| Yes | 2.602 | 1.364−4.962 | 0.0037 | ||||||||
| SCC-Ag* | 1.034 | 1.004−1.065 | 0.0278 | ||||||||
| Cervical stromal invasion | |||||||||||
| <1/3 | 1 | ||||||||||
| 1/3−2/3 | 4.962 | 1.871−13.159 | 0.0013 | ||||||||
| >2/3 | 4.764 | 1.731−13.108 | 0.0025 | ||||||||
| Tumor size (cm) | |||||||||||
| ≤4 | 1 | ||||||||||
| >4 | 1.874 | 1.014−3.463 | 0.0449 | ||||||||